VeriMomtroxerutin hamilelikte güvenli mi?
Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
Hamilelikte troxerutin yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- troxerutin hamilelikte güvenli mi?
- Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
- troxerutin emzirirken güvenli mi?
- Animal reports indicate traces of hydroxyethylrutosides can be found in milk after systemic (oral) dosing; combined with the human epidemiology above this supports a suspected hazard for systemic use. For topical cosmetic use in the mother, systemic absorption is expected to be negligible and transfer via breast milk from topical use is considered negligible.
- troxerutin bebek cildi için güvenli mi?
- Hazard is retained (suspected) because evidence exists for reproductive/ developmental effects with systemic exposures to hydroxyethylrutosides. Mechanistic reproductive toxicity data specific to troxerutin were not found. Dermal absorption from cosmetic use is expected to be very low in adults (e=0), but infant (0–3 yr) skin has increased permeability and higher surface-area-to-weight, so exposure is increased by +1 (e=1) compared with adults despite limited direct absorption data.
- VeriMom troxerutin nasıl puanlıyor?
- VeriMom troxerutin'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 60/100 (orta risk) olarak puanlar.
- Hamilelikte troxerutin yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.